249 related articles for article (PubMed ID: 31448450)
1. Review article: direct-acting antivirals for the treatment of HCV during pregnancy and lactation - implications for maternal dosing, foetal exposure, and safety for mother and child.
Freriksen JJM; van Seyen M; Judd A; Gibb DM; Collins IJ; Greupink R; Russel FGM; Drenth JPH; Colbers A; Burger DM
Aliment Pharmacol Ther; 2019 Oct; 50(7):738-750. PubMed ID: 31448450
[TBL] [Abstract][Full Text] [Related]
2. Direct-Acting Antivirals to Prevent Vertical Transmission of Viral Hepatitis C: When Is the Optimal Time to Treat?
Cervino L; Hynicka LM
Ann Pharmacother; 2018 Nov; 52(11):1152-1157. PubMed ID: 29681166
[TBL] [Abstract][Full Text] [Related]
3. Revolutionizing hepatitis C treatment: next-gen direct-acting antivirals.
Dobrowolska K; Brzdęk M; Rzymski P; Flisiak R; Pawłowska M; Janczura J; Brzdęk K; Zarębska-Michaluk D
Expert Opin Pharmacother; 2024 May; 25(7):833-852. PubMed ID: 38768013
[TBL] [Abstract][Full Text] [Related]
4. Direct antiviral agents (DAAs) and their use in pregnant women with hepatitis C (HCV).
Abdul Massih S; Eke AC
Expert Rev Anti Infect Ther; 2022 Nov; 20(11):1413-1424. PubMed ID: 36111676
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C Virus Infection in Pregnancy and Children: Its Implications and Treatment Considerations with Directly Acting Antivirals: A Review.
Rana R; Dangal R; Singh Y; Gurung RB; Rai B; Sharma AK
JNMA J Nepal Med Assoc; 2021 Sep; 59(241):942-953. PubMed ID: 35199739
[TBL] [Abstract][Full Text] [Related]
6. Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas.
Merli M; Frigeni M; Alric L; Visco C; Besson C; Mannelli L; Di Rocco A; Ferrari A; Farina L; Pirisi M; Piazza F; Loustaud-Ratti V; Arcari A; Marino D; Sica A; Goldaniga M; Rusconi C; Gentile M; Cencini E; Benanti F; Rumi MG; Ferretti VV; Grossi P; Gotti M; Sciarra R; Tisi MC; Cano I; Zuccaro V; Passamonti F; Arcaini L
Oncologist; 2019 Aug; 24(8):e720-e729. PubMed ID: 30552159
[TBL] [Abstract][Full Text] [Related]
7. Evidence for Implementation: HIV/HCV Coinfection and Pregnancy.
Curtis MR; Chappell C
Curr HIV/AIDS Rep; 2023 Feb; 20(1):1-8. PubMed ID: 36652107
[TBL] [Abstract][Full Text] [Related]
8. Direct acting antivirals failure: cause and retreatment options.
Parlati L; Pol S
Expert Rev Gastroenterol Hepatol; 2018 Dec; 12(12):1245-1250. PubMed ID: 30791789
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C Virus in Pregnancy: An Opportunity to Test and Treat.
Fogel RS; Chappell CA
Obstet Gynecol Clin North Am; 2023 Jun; 50(2):363-373. PubMed ID: 37149316
[TBL] [Abstract][Full Text] [Related]
10. Modelling the potential effectiveness of hepatitis C screening and treatment strategies during pregnancy in Egypt and Ukraine.
Hachicha-Maalej N; Collins IJ; Ades AE; Scott K; Judd A; Mostafa A; Chappell E; Hamdy-El-Sayed M; Gibb D; Pett S; Mariné-Barjoan E; Volokha A; Yazdanpanah Y; Deuffic-Burban S
J Hepatol; 2023 May; 78(5):937-946. PubMed ID: 36669704
[TBL] [Abstract][Full Text] [Related]
11. Responsible Inclusion of Pregnant Individuals in Eradicating HCV.
Jhaveri R; Yee LM; Antala S; Murphy M; Grobman WA; Shah SK
Hepatology; 2021 Sep; 74(3):1645-1651. PubMed ID: 33743550
[TBL] [Abstract][Full Text] [Related]
12. Racial/Ethnic and Socioeconomic Disparities in Use of Direct-Acting Antivirals Among Medicare Beneficiaries with Chronic Hepatitis C, 2014-2016.
Jung J; Du P; Feldman R; Kong L; Riley T
J Manag Care Spec Pharm; 2019 Nov; 25(11):1236-1242. PubMed ID: 31663464
[TBL] [Abstract][Full Text] [Related]
13. Real-world treatment for chronic hepatitis C infection in Germany: Analyses from drug prescription data, 2010-2015.
Zimmermann R; Kollan C; Ingiliz P; Mauss S; Schmidt D; Bremer V
J Hepatol; 2017 Jul; 67(1):15-22. PubMed ID: 28189752
[TBL] [Abstract][Full Text] [Related]
14. Disparities in direct acting antivirals uptake in HIV-hepatitis C co-infected populations in Canada.
Saeed S; Strumpf EC; Moodie EE; Young J; Nitulescu R; Cox J; Wong A; Walmsely S; Cooper C; Vachon ML; Martel-Laferriere V; Hull M; Conway B; Klein MB;
J Int AIDS Soc; 2017 Nov; 20(3):. PubMed ID: 29116684
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Hepatitis C during Pregnancy-Weighing the Risks and Benefits in Contrast to HIV.
Barritt AS; Jhaveri R
Curr HIV/AIDS Rep; 2018 Apr; 15(2):155-161. PubMed ID: 29470782
[TBL] [Abstract][Full Text] [Related]
16. Trends in HCV treatment uptake, efficacy and impact on liver fibrosis in the Swiss HIV Cohort Study.
Béguelin C; Suter A; Bernasconi E; Fehr J; Kovari H; Bucher HC; Stoeckle M; Cavassini M; Rougemont M; Schmid P; Wandeler G; Rauch A;
Liver Int; 2018 Mar; 38(3):424-431. PubMed ID: 28741901
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus: A Review of Cases Reported to the U.S. Food and Drug Administration Adverse Event Reporting System.
Bersoff-Matcha SJ; Cao K; Jason M; Ajao A; Jones SC; Meyer T; Brinker A
Ann Intern Med; 2017 Jun; 166(11):792-798. PubMed ID: 28437794
[TBL] [Abstract][Full Text] [Related]
18. Direct-Acting Antiviral Agents for Patients With Hepatitis C Virus Genotype 1 Infection Are Cost-Saving.
Chhatwal J; He T; Hur C; Lopez-Olivo MA
Clin Gastroenterol Hepatol; 2017 Jun; 15(6):827-837.e8. PubMed ID: 27650326
[TBL] [Abstract][Full Text] [Related]
19. Health care utilization and costs associated with direct-acting antivirals for patients with substance use disorders and chronic hepatitis C.
Jiang X; Vouri SM; Diaby V; Lo-Ciganic W; Parker R; Park H
J Manag Care Spec Pharm; 2021 Oct; 27(10):1388-1402. PubMed ID: 34595949
[No Abstract] [Full Text] [Related]
20. Safety and effectiveness of direct acting antivirals for treatment of hepatitis C virus in patients with solid organ transplantation.
Mansour M; Hill L; Kerr J
Transpl Infect Dis; 2018 Dec; 20(6):e12972. PubMed ID: 30080955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
